LP-IR Score

The LP-IR Score is a metric derived from a lipid panel blood test intended to identify insulin resistance in the setting of normoglycemia, before the onset of prediabetes.   [12.]  It was developed to identify insulin resistance up to years prior to the onset of overt blood sugar dysregulation.  [6.]

Comprising six components extracted from the lipid panel, the LP-IR Score offers valuable insights into the intricate interplay between glucose levels, lipid metabolism and insulin sensitivity. Understanding this score is integral to comprehending one's risk for metabolic disorders and implementing preventive measures to mitigate potential health concerns related to insulin resistance and glucose dysregulation.

Overview of LP-IR Score

What is the LP-IR Score?

The LP-IR Score is a metric derived from a standard lipid panel blood test intended to identify insulin resistance in the setting of normoglycemia before the onset of prediabetes.   [12.]

The LP-IR Score is obtained from analyzing six key parameters within a lipid panel via nuclear magnetic resonance spectroscopy as a weighted score: 

• VLDL, LDL and HDL particle sizes 
• Their subsets concentrations: specifically, large VLDL, small LDL, and large HDL particle concentrations

These components are more strongly correlated with insulin resistance than any other single marker, as they reflect the intricate relationship between lipid metabolism and insulin sensitivity.  [5.]

By quantifying the degree of dyslipidemia and its implications for insulin resistance, the LP-IR Score provides clinicians with a holistic assessment of metabolic health and facilitates personalized treatment strategies tailored to each patient's needs.

Relationship to Insulin Resistance and Metabolic Health

The Lipoprotein Insulin Resistance Score (LP-IR) serves as a comprehensive marker of dyslipoproteinemia, capturing the complex effects of insulin resistance on lipoprotein metabolism. 

It is understood that alterations in lipid profiles, specifically elevations in triglycerides and reductions in high density lipoprotein cholesterol are early markers of metabolic dysfunction.  [11.]  The LP-IR is an extension of the understanding that dyslipidemia may be an early marker of insulin resistance, occurring in the setting of normal glucose levels.  [12.]

Utilizing a targeted metabolomics approach with nuclear magnetic resonance spectroscopy, LPIR quantifies various aspects of lipoprotein particle size and concentration, including VLDL, LDL, and HDL subclasses. This composite score demonstrates a stronger association with insulin resistance than individual lipid subclasses. 

Recent research has linked elevated LPIR levels with a heightened risk of incident type 2 diabetes (T2D), even among healthy individuals and individuals receiving high-intensity statin treatment.  [6.]

In a large-scale study involving over 29,000 non-diabetic middle-aged women, baseline LPIR levels were examined for their predictive value in identifying T2D risk over a 20-year follow-up period. Additionally, the study aimed to assess whether incorporating LPIR into risk prediction models could enhance T2D risk stratification beyond traditional clinical parameters.  [6.]

The following is taken directly from their research paper:

“In middle aged or older healthy women followed prospectively over 20 years, LPIR was robustly associated with incident T2D, including among those with an optimal clinical metabolic profile. LPIR improved T2D risk classification and may guide early and targeted prevention strategies.”  [6.]

Testing Procedure

Testing for the Lipoprotein Insulin Resistance Score (LP-IR) requires a blood sample. Blood samples are typically drawn from the patient and collected in tubes containing anticoagulants to prevent clotting. 

Once collected, the samples are transported to the laboratory for processing via high-throughput nuclear magnetic resonance (NMR) spectroscopy for the analysis of lipoprotein particles. 

This technique allows for the quantification of various lipoprotein subclasses, including very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL), based on their distinct spectroscopic signatures.

The spectroscopic data obtained from the NMR analysis are then processed using specialized software algorithms to calculate the Lipoprotein Insulin Resistance Score (LP-IR). This score integrates information from different lipoprotein subclasses to provide a comprehensive assessment of insulin resistance and metabolic health. 

Clinical Interpretation and Significance of the LP-IR Score

Interpretation of LP-IR Score

Th eLP-IR score is reported as a score between 0 and 100, with 0 being the most insulin sensitive and 100 being the most insulin resistant.  

Clinical Significance of the LP-IR Score

One well-known study reports that a score above 48 indicates insulin resistance.  [5.]  Many labs report a cut-off for insulin resistance above 45.  [9., 10.]

An LP-IR score above 45 should be interpreted within the context of an individual’s full health history and diet and lifestyle habits.  Diet and lifestyle interventions to increase insulin sensitivity should be considered.  Additionally, certain medications such as statins may be considered appropriate.

How to Lower LP-IR Score

Lifestyle Modifications

• Maintain a healthy weight through regular physical activity and a balanced diet.  [17.]
• Reduce sedentary behavior and incorporate more movement throughout the day.
• Manage stress levels through relaxation techniques such as meditation or yoga.  [16.]
• Ensure adequate sleep duration and quality to support metabolic health.  [13.]

Dietary Changes  [3.]

• Consume a diet rich in whole foods, including fruits, vegetables, whole grains, lean proteins, and healthy fats.  
• Limit intake of highly processed foods, sugary beverages, and foods high in saturated and trans fats.
• Increase fiber intake from sources like legumes, nuts, seeds, and whole grains to promote satiety and regulate blood sugar levels.
• Monitor portion sizes and practice mindful eating to prevent overeating and promote weight management.
• Consider reducing carbohydrate intake, particularly refined carbohydrates, and opting for complex carbohydrates with a lower glycemic index.  [4.]

Exercise Recommendations  [1., 15.]

• Engage in a combination of aerobic exercise, strength training, and flexibility exercises to improve insulin sensitivity and metabolic function.
• Aim for regular physical activity throughout the week, incorporating both cardiovascular exercise and resistance training sessions.
• Gradually increase exercise intensity and duration over time to challenge the body and promote fitness gains.
• Incorporate activities you enjoy to increase adherence to exercise routines and maintain long-term consistency.
• Consult with a healthcare provider or fitness professional to develop a personalized exercise plan based on individual fitness levels and health goals.

Medication and Supplement Options

• Consult with a healthcare provider to discuss medication options for managing insulin resistance and related conditions such as type 2 diabetes or dyslipidemia.
• Consider medications such as metformin or statins under the guidance of a healthcare provider to help improve insulin sensitivity and lipid profiles.
• Discuss the potential benefits of supplements such as omega-3 fatty acids, vitamin D, and chromium picolinate with a healthcare provider to support metabolic health and insulin sensitivity.  [7., 8., 14.]
• Follow recommended dosages and precautions when using medications or supplements, and inform healthcare providers of any existing medical conditions or medications being taken.

Follow-Up and Monitoring

• Schedule regular follow-up appointments with healthcare providers to monitor progress and adjust treatment plans as needed.
• Track changes in LP-IR score, lipid profiles, blood sugar levels, and other relevant markers through periodic blood tests and assessments.
• Maintain open communication with healthcare providers regarding any changes in symptoms, lifestyle habits, or medication adherence.
• Discuss strategies for overcoming barriers to adherence with lifestyle modifications or medication regimens, and seek support from healthcare professionals or support groups as needed.
• Stay informed about new research and developments in the management of insulin resistance and metabolic health to make informed decisions about treatment options and lifestyle choices.

Order an LP-IR Test

Click here to order an LP-IR test.